Lung cancer symposium nov 2020
MedGenome cordially invites you to a Virtual Symposium on
Lung cancer and Genetics
Lung cancer is the most common cancer diagnosed worldwide. It is also the foremost contributor to cancer-related mortality, resulting in 1.38 million cancer deaths per year worldwide. There is a significant burden of lung cancer in India as well.
The presence of genetic alterations in the cancer cells which drive the growth of the tumor (Driver Alterations) allows the selection of treatment regime for individual NSCLC patients.
Genetic testing identifies the presence of oncogenic drivers and hence helps indicate the apt targeted treatment regimen improving the probability of patient survival as well as the quality of life.
As a part of our endeavour to create awareness on the topic of lung cancer and the role of genetics, we bring together senior doctors and scientists from the field to speak with you and share experiences during this Lung Cancer Awareness Month.
This symposium will be an amalgamation of genetic diagnostics and clinical experience in cancer treatment. It will focus on genetic diagnostic approaches for lung cancer and how these have empowered doctors in clinical practice to make informed treatment decisions.
Dr. Boben Thomas
Consultant Medical & Pediatric Oncologist, Caritas Hospital Kottayam and GG Hospital, Trivandrum
Dr. Tushar Patil
Consultant Medical Oncologist at Sahyadri Hospitals, Pune
Dr. Mithun Shah
Senior Consultant Medical & Hemato Oncologist, Zydus Hospitals, Ahmedabad
Dr. Arun Kumar
Scientific Affairs, Medgenome Labs
|7 p.m.||Welcome and acknowledge the speakers and attendees||Ganesh Mahajan, Marketing Manager, MedGenome Labs|
|7:05 p.m.||Speaker Introduction||Dr. Arun Kumar, Scientific Affairs, Medgenome Labs|
|7.10-7.30 p.m.||Somatic EGFR Mutations in NSCLC and their Therapeutic Implications||Dr. Boben Thomas, Consultant Medical & Pediatric Oncologist, Caritas Hospital Kottayam and GG Hospital, Trivandrum.|
|7:30-7.50 p.m.||Molecular and Genetic Aspects of Lung Cancer|
Dr. Tushar Patil, Consultant Medical Oncologist at Sahyadri Hospitals, Pune
|7.50 – 8:10 p.m.||PD L1 testing and its significance in Lung Cancer||Dr. Mithun Shah, Senior Consultant Medical & Hemato Oncologist, Zydus Hospitals, Ahmedabad|
|8.10 – 8:30 p.m.||Genomic technologies in NSCLC testing and interpreting Next Generation Sequencing Reports||Dr. Arun Kumar, Scientific Affairs, Medgenome Labs|
|8.30- 8:40 p.m.||Open the floor for Q+A OR The anchor to read out the questions to be addressed.||Ganesh Mahajan, Marketing Manager, MedGenome Labs|